Flunarizine Dihydrochloride Suppliers & Bulk Manufacturers
Available Forms: Oral tablets
Available Strengths: 5 mg tablets, 10 mg tablets
Reference Brands: Sibelium, Flunalix, Vertinex(EU)
Category:
Antipsychotropic Drugs
Flunarizine Dihydrochloride is used in migraine prevention and vertigo treatment. Available in 5 mg and 10 mg tablets in the EU under brands like Sibelium, it's not approved in the US. Pharma B2B buyers source it for neurology markets due to its strong demand in chronic neurological care.
Flunarizine Dihydrochloride is available in Oral tablets
and strengths such as 5 mg tablets, 10 mg tablets.
Sourced from GMP-certified and ISO-compliant manufacturers, this API meets
global pharmacopeia standards (USP/EP/JP as applicable). Ideal for pharmaceutical
formulation and commercial manufacturing, Flunarizine Dihydrochloride is supplied in
bulk quantities with complete regulatory support including DMF, COA, and MSDS.
|
Technical Specifications & Supply Details
|
| Lead Time |
7 to 60 days (depending on batch size & schedule) |
| MOQ |
As per manufacturer’s batch size |
| COA |
Available with every batch |
| Regulatory Dossier / DMF |
Available upon request |
| Export Documentation |
FSC, COA, Manufacturing License, Product Permission |
| Standards |
IP, BP, USP |
| Certifications |
WHO-GMP, EU-GMP, USFDA (as applicable) |
Flunarizine Dihydrochloride can be exported to over 30 countries across Asia, Africa, Europe,
and Latin America. Flexible packaging, competitive pricing, and a verified supplier
network make Pharmatradz a trusted sourcing partner for pharmaceutical companies
and contract manufacturers worldwide.
Product Description:
Flunarizine Dihydrochloride is a calcium channel blocker widely prescribed in Europe for the prevention of migraines, treatment of vertigo, and management of certain cerebrovascular disorders. Available in oral tablet form (5 mg and 10 mg), it is marketed under brand names like Sibelium in countries including Belgium, Italy, and Spain. Though not approved in the US, Flunarizine has broad pharmaceutical demand in EU and global markets for neurology and ENT-related applications. Pharma B2B suppliers cater to healthcare providers and distributors seeking quality Flunarizine formulations. Its long half-life and proven efficacy make it a popular choice for chronic neurological care.
Disclaimer: By continuing to browse, you agree to the terms of use of this website and the Trade Marks displayed, in compliance with the provisions of the Trademark Act, 1999, Section 30 and 30(1) under 'Fair use.'
The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Back to Listing